Expanding the Potential of Large-scale Cohort Studies Through UK-Japan Collaboration
Information
UK and Japan share a common goal in utilising large-scale cohort studies to understand the genetic, lifestyle and environmental causes of disease to improve the health of society. The recent evolution and cost reduction of complex sample assays, such as genome and other -omic measures, as well as the progress of large-scale data analysis methods, have greatly expanded the opportunities provided by these resources.
UK Biobank is an intensively characterised prospective cohort of 500,000 UK participants, with ongoing data collection and linkage to electronic health records. Accessible to approved researchers anywhere in the world, its large-scale biomedical database contains in-depth genetic and health information including exome, genome, metabolome and (soon) proteome data. Tohoku Medical Megabank Organisation is a large-scale biobank for the general public that represents Japan and Asia, consisting of bio-specimen and information on cohort studies, genome information, and metabolome information from 150,000 participants.
Cooperation between large-scale cohort studies established in each region of the world is expected to further expand the benefits for society. With this view, this symposium is intended to introduce the characteristics of these resources in Japan and the UK, and to discuss opportunities and benefits for future collaboration.
Date
Thursday, March 10, 2022 17:00 – 20:30 (JST) / 8:00 – 11:30 (GMT)
Venue
Zoom (simultaneous interpretation provided) and Conference Room, Building for Tohoku Medical Megabank Project 3F
Speakers
Naomi Allen (UK Biobank)
Rory Collins (UK Biobank)
Mark Effingham (UK Biobank)
Yoko Izumi (Tohoku University)
Kengo Kinoshita (Tohoku University)
Shinichi Kuriyama (Tohoku University)
Ben Lacey (UK Biobank)
Masayuki Yamamoto (Tohoku University)
Registration
Registration Deadline: Tuesday, March 8, 2022 17:00 (JST)
– Closed
Time Schedule [Mar. 8, 2022 Updated]
- MC: Fuji Nagami (Tohoku University)
- 17:00 – 17:10
- Opening Remarks
- Mark Palmer (Medical Research Council)
Sakamoto Shuichi (Ministry of Education, Culture, Sports, Science and Technology)
Julia Longbottom (British Ambassador to Japan) (video message)
- Chair: Rory Collins (UK Biobank)
- 17:10 – 17:40
- Naomi Allen (UK Biobank)
Ben Lacey (UK Biobank) - UK Biobank: an international resource for studying the determinants of disease
- 17:40 – 18:10
- Shinichi Kuriyama (Tohoku University)
- Strategic Design, Progress and Perspective of ToMMo's cohort studies
- 18:10 – 18:15
- Q&A
- Chair: Masayuki Yamamoto (Tohoku University)
- 18:15 – 18:45
- Mark Effingham (UK Biobank)
- UK Biobank: whole genome sequencing and public/private partnership
- 18:45 – 19:15
- Kengo Kinoshita (Tohoku University)
- Current status of genome and omics study and future direction by ToMMo
- 19:15 – 19:20
- Q&A
- Chair: Rory Collins (UK Biobank)
- 19:20 – 19:50
- Naomi Allen (UK Biobank)
- UK Biobank: future enhancements and extending sample assays
- 19:50 – 20:20
- Yoko Izumi (Tohoku University)
- Progress of ToMMo Integrated Biobank and related studies
- 20:20 – 20:25
- Q&A
- 20:25 – 20:30
- Closing Remarks
- Masayuki Yamamoto (Tohoku University)
Rory Collins (UK Biobank)
Poster
– Download [PDF]